 |  | |
 |
|
| Educational background |
| |
M.D., Qingdao Medical College, 1982
|
|
| Areas of expertise |
| |
| Aromatase | Androstenedione |
| Heart | Myocardial Ischemia |
| Neurons, Afferent | Sympathetic Nervous System |
| Diabetic Neuropathies | Neurons |
| Spinothalamic Tracts | Afferent Pathways |
| Ganglia, Spinal | Hyperalgesia |
| Nerve Fibers, Myelinated | Nociceptors |
| Diabetes Mellitus, Experimental | Enkephalin, D-Penicillamine (2,5)- |
| Nitric Oxide | Posterior Horn Cells |
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | GTP-Binding Proteins |
| Receptors, Opioid, mu | Paraventricular Hypothalamic Nucleus |
| Receptors, Presynaptic | Spinal Cord |
| gamma-Aminobutyric Acid | Locus Coeruleus |
| Naltrexone | Receptors, Opioid, delta |
| Analgesics, Opioid | Pain |
| Blood Circulation | Viscera |
| Acetylcholine | Morphine |
| Analgesics | Cholinesterase Inhibitors |
| Neostigmine | Anticonvulsants |
| Sciatic Neuropathy | Neuroprotective Agents |
| Organophosphorus Compounds | Receptors, GABA-B |
| Receptors, Muscarinic | Cholinergic Agents |
| Diterpenes | Heat |
| Neuralgia | Angiotensin II |
| Neural Inhibition | Presynaptic Terminals |
| Muscarine | Muscarinic Agonists |
| Pirenzepine | Receptors, Drug |
| Reflex | Penicillamine |
| Signal Transduction | Synapses |
| Medulla Oblongata | Synaptic Transmission |
| Excitatory Postsynaptic Potentials | Glutamic Acid |
| Somatostatin | Calcium Channels, N-Type |
| Escherichia coli | Calcium Channels, Q-Type |
| Metalloproteins | Calcium Channels, P-Type |
| Oxygen | Narcotics |
| Receptors, Adrenergic, alpha-2 | Plant Lectins |
| Iron | Ribonucleotide Reductases |
| Aminobutyric Acids | Receptors, Metabotropic Glutamate |
| Amygdala | Periaqueductal Gray |
| Receptor, Muscarinic M2 | Receptor, Muscarinic M3 |
| Receptor, Muscarinic M4 | Membrane Potentials |
| Potassium Channels, Voltage-Gated | Calcineurin |
| Calcium Channels | Down-Regulation |
| Ion Channels | Amines |
| Cyclohexanecarboxylic Acids | Disease Models, Animal |
| Pain Threshold | Neural Pathways |
| Parasympathetic Nervous System | Glycine |
| Peripheral Nervous System Diseases | Brain |
| Obsessive-Compulsive Disorder | Psychotropic Drugs |
|
|
| Publication author name |
|
| Select publications |
|
|
|
|
|
